SI-BONE, Inc.
For the period ended Dec 31, 2025. Filed Apr 21, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 31, 2025 · Filed Apr 21, 2026
Contents
APPENDIX A
This proxy statement contains information regarding certain non-GAAP financial measures, including Adjusted EBITDA, which is not calculated in accordance with Generally Accepted Accounting Principles (“GAAP”). Adjusted EBITDA excludes from net loss the effects of interest income, interest expense, depreciation and amortization and stock-based compensation. We use non-GAAP financial measures internally in analyzing our financial results and believe that the use of non-GAAP financial measures, including Adjusted EBITDA, is useful as an additional tool to evaluate ongoing operating results and trends and in comparing our financial results with other companies in our industry, many of which present similar non-GAAP financial measures.
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. We encourage stockholders to carefully consider our GAAP results, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. A reconciliation of non-GAAP measures to the most directly comparable GAAP measure is provided below.
The following table presents a reconciliation of GAAP and non-GAAP results:
| RECONCILIATION OF NET LOSS TO NON-GAAP ADJUSTED EBITDA(In thousands) | |||
|---|---|---|---|
| Twelve Months Ended December 31, | |||
| 2025 ($) | 2024 ($) | 2023 ($) | |
| Net loss on a GAAP basis | (18,904) | (30,913) | (43,336) |
| Add (Subtract): | |||
| Interest income | (6,074) | (7,848) | (6,916) |
| Interest expense | 2,628 | 3,440 | 3,462 |
| Depreciation and amortization | 5,770 | 4,379 | 5,428 |
| Stock-based compensation | 25,524 | 25,868 | 24,057 |
| Adjusted EBITDA on a non-GAAP basis | 8,944 | (5,074) | (17,305) |
| SI-BONE, Inc. | 57 | 2026 Proxy Statement |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.